Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study

• Published in: BMJ Vol. 315; no. 7115; pp. 1045 - 1049
• Main Authors: Kuusisto, Johanna, Koivisto, Keijo, Mykkänen, Leena, Helkala, Eeva-Liisa, Vanhanen, Matti, Hänninen, Tuomo, Kervinen, Kari, Kesäniemi, Y Antero, Riekkinen, Paavo J, Laakso, Markku
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 25.10.1997; British Medical Association; BMJ Publishing Group LTD; BMJ Publishing Group
• Edition: International edition
• Subjects: Aged; Alzheimer Disease - epidemiology; Alzheimer Disease - genetics; Alzheimer's disease; Alzheimers disease; Apolipoprotein E4; Apolipoproteins E - genetics; Cholesterols; Cross-Sectional Studies; Dementia; Diabetes; Drug resistance; Fasting; Female; Finland - epidemiology; Follow-Up Studies; Humans; Hyperinsulinism - epidemiology; Hyperinsulinism - genetics; Insulin; Insulin resistance; Insulin Resistance - genetics; Logistic Models; Male; Medical research; Neurology; Phenotype; Phenotypes; Predisposing factors; Risk Factors; Type 2 diabetes mellitus; Finland
• ISSN: 0959-8138; 0959-8146; 1468-5833; 1756-1833
• DOI: 10.1136/bmj.315.7115.1045

Abstract Objective: To determine the association between features of the insulin resistance syndrome and Alzheimer's disease. Design: Cross sectional population based study. Subjects: 980 people aged 69 to 78 (349 men, 631 women). Setting: Population of Kuopio, eastern Finland. Main outcome measures: Presence of features of the insulin resistance syndrome and diagnosis of Alzheimer's disease by detailed neurological and neuropsychological evaluation. Results: 46 (4.7%) subjects were classified as having probable or possible Alzheimer's disease. In univariate analyses, apolipoprotein E4 phenotype (odds ratio; 95% confidence interval 3.24: 1.77 to 5.92), age (1.16; 1.05 to 1.29), low level of education (0.82; 0.72 to 0.93), low total cholesterol concentration (0.77; 0.59 to 1.00), high systolic blood pressure (1.01; 1.00 to 1.03), high fasting and 2 hour plasma glucose concentrations (1.11; 1.01 to 1.23 and 1.08; 1.03 to 1.13, respectively), high fasting and 2 hour insulin concentrations (1.05; 1.02 to 1.08 and 1.003; 1.00 to 1.01, respectively), and abnormal glucose tolerance (1.86; 1.23 to 2.80) were significantly associated with Alzheimer's disease. In multivariate analysis including apolipoprotein E4 phenotype, age, education, systolic blood pressure, total cholesterol concentration, fasting glucose concentration, and insulin concentration, apolipoprotein E4 phenotype, age, education, total cholesterol, and insulin were significantly associated with Alzheimer's disease. In 532 non-diabetic subjects without the e4 allele hyperinsulinaemia was associated with an increased risk for Alzheimer's disease (prevalence of disease 7.5% v 1.4% in normoinsulinaemic subjects, P=0.0004). In contrast, in the 228 with the e4 allele hyperinsulinaemia had no effect on the risk of disease (7.0% v 7.1%, respectively). Conclusion: Features of the insulin resistance syndrome are associated with Alzheimer's disease independently of apolipoprotein E4 phenotype. Key messages Apolipoprotein E4 phenotype is a risk factor for Alzheimer's disease Other risk factors for Alzheimer's disease are not well documented in previous studies In this study, hyperinsulinaemia and other features of the insulin resistance syndrome were associated with Alzheimer's disease Insulin resistance is affected by modifications in lifestyle, so the risk of Alzheimer's disease might be reducible by the same measures